Approved Products
| LICENSEE/PARTNER | PRODUCT NAME | GENERIC NAME | PRIMARY INDICATION | MARKETED |
| ORAL | ||||
| GlaxoSmithKline | Paxil CR™ | paroxetine | Depression | |
| Requip® XL 24-Hour™ | ropinirole | Parkinson’s disease | ||
| sanofi-aventis | Xatral® OD/ Uroxatral® | alfuzosin | BPH (urinary symptoms) | |
| Sciele Pharma | Triglide® | fenofibrate | Lipid disorders | |
| Sular® Geomatrix™ | nisoldipine | Hypertension | ||
| Roche | Madopar DR® | levodopa + benserazide | Parkinson’s disease | |
| Critical Therapeutics | ZYFLO CR™ | zileuton | Asthma | |
| Therabel | Coruno® | molsidomine | Angina | |
| Ratiopharm | diclofenac-ratiopharm® uno | diclofenac | Pain/inflammation | |
| INHALATION | ||||
| AstraZeneca | Pulmicort® HFA-MDI | budesonide | Asthma | |
| Novartis | Foradil® Certihaler® | formoterol | Asthma | |
| TOPICAL | ||||
| Nycomed/Almirall | Solaraze® | diclofenac | Actinic keratosis | |
Copyright 2008, SkyePharma. All Rights Reserved.
SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 105 Piccadilly, London, W1J 7NJ, United Kingdom